1. Neurofilament light chain as a promising biomarker for depression diagnosis: a systematic review and meta-analysis
- Author
-
Adrina Habibzadeh, Vahid Reza Ostovan, Mohammad Amin Ghezel, Kiarash Kavari, Sina Kardeh, and Reza Tabrizi
- Subjects
Depression ,Neurofilament light chain ,Review ,Axonal damage ,Diagnosis ,Biomarkers ,Psychiatry ,RC435-571 - Abstract
Abstract Background Depression is a prevalent and serious mental health disorder that significantly impacts daily life and functioning. Neurofilament Light chain (NfL), associated with axonal neuronal damage, has been identified as a promising biomarker, potentially aiding in early diagnosis of depression, personalized treatment, and tracking disease progression. This study used meta-analysis to evaluate the potential of plasma NfL as a biomarker for depression patients. Methods A systematic search following the PRISMA guidelines was conducted across PubMed, Web of Science, Scopus, and Google Scholar databases to find relevant studies on plasma NfL levels in patients with depression. A random effects model meta-analysis was applied to determine its potential as a biomarker for differentiating patients from controls. Results Our meta-analysis, based on four articles with six datasets, revealed that plasma NfL levels were notably higher in individuals with depression (228 cases) compared to healthy controls (118 individuals). The weighted mean difference (WMD) was 8.78 (95% CI: 5.28, 12.28; P
- Published
- 2024
- Full Text
- View/download PDF